The IKK complex: An integrator of all signals that activate NF-κB?

Trends in Cell Biology

Volumn 10, Issue 4, 2000, Pages 129-133

  Israël, Alain ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE;

CELL ACTIVATION; CELL COMMUNICATION; COMPLEX FORMATION; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME SUBUNIT; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 0034175930     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(00)01729-3     Document Type: Conference Paper

References (46)

1. Ghosh S.et al. NF-κB and rel proteins - evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
2. Baldwin A.S. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
3. Whiteside S.T., Israel A. IκB proteins - structure, function and regulation. Sem. Cancer Biol. 8:1997;75-82.
4. Beg A.A., Baldwin A.S. The IκB proteins - multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:1993;2064-2070.
5. Verma I.M.et al. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:1995;2723-2735.
6. Regnier C.H.et al. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
7. Rothwarf D.M.et al. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-300.
8. Yamaoka S.et al. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240.
9. Didonato J.A.et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554.
10. Mercurio F.et al. IKK-1 and IKK-2 - cytokine-activated IκB kinases essential for NF-κB activation. Science. 278:1997;860-866.
11. Woronicz J.D.et al. IκB-kinase-β-NF-κB activation and complex formation with IκB kinase-α and NIK. Science. 278:1997;866-869.
12. Zandi E.et al. The IκB kinase complex (IKK) contains two kinase subunits, IKK-α and IKK-β, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.
13. Mercurio F.et al. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19:1999;1526-1538.
14. Mercurio F., Manning A.M. Multiple signals converging on NF-κB. Curr. Opin. Cell Biol. 11:1999;226-232.
15. Zandi E., Karin M. Bridging the gap: composition, regulation and physiological function of the IκB kinase complex. Mol. Cell. Biol. 19:1999;4547-4551.
16. Maniatis T. A ubiquitin ligase complex essential for the NF-κ B, Wnt/Wingless, and Hedgehog signaling pathways. Genes Dev. 13:1999;505-510.
17. Delhase M.et al. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science. 284:1999;309-313.
18. Li Z.W.et al. The IKKβ subunit of IκB kinase (IKK) is essential for Nuclear Factor kappa B activation and prevention of apoptosis. J. Exp. Med. 189:1999;1839-1845.
19. Li Q.T.et al. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science. 284:1999;321-325.
20. Tanaka M.et al. Embryonic lethality, liver degeneration and impaired NF-κB activation in IKKβ-deficient mice. Immunity. 10:1999;421-429.
21. Li Q.T.et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1999;1322-1328.
22. Hu Y.L.et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science. 284:1999;316-320.
23. Takeda K.et al. Limb and skin abnormalities in mice lacking IKKα Science. 284:1999;313-316.
24. Seitz C.S.et al. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl. Acad. Sci. U. S. A. 95:1998;2307-2312.
25. van Hogerlinden M.et al. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappa B signaling. Cancer Res. 59:1999;3299-3303.
26. Kanegae Y.et al. Role of rel/NF-κB transcription factors during the outgrowth of the vertebrate limb. Nature. 392:1998;611-614.
27. Bushdid P.B.et al. Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature. 392:1998;615-618.
28. Chu Z.L.et al. IKKγ mediates the interaction of cellular IκB kinases with the Tax transforming protein of human-T-cell-leukemia-virus type 1. J. Biol. Chem. 274:1999;15297-15300.
29. Rudolph D.et al. Severe liver degeneration and lack of NF-κB activation in NEMO/IKK-γ deficient mice. Genes Dev. 2000;. (in press).
30. Li Y.et al. Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1042-1047.
31. Cohen L.et al. IKAP is a scaffold protein of the IκB kinase complex. Nature. 395:1998;292-296.
32. Heilker R.et al. The kinetics of association and phosphorylation of IκB isoforms by IκB kinase 2 correlate with their cellular regulation in human endothelial cells. Biochemistry. 38:1999;6231-6238.
33. Shimada T.et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Int. Immunol. 11:1999;1357-1362.
34. Peters R.T.et al. IKKε is part of a novel PMA-inducible IκB kinase complex. Mol. Cell. 2000;. (in press).
35. Arch R.H.et al. Tumor-necrosis-factor-receptor-associated factors (TRAFs) - a family of adaptor proteins that regulates life and death. Genes Dev. 12:1998;2821-2830.
36. Ninomiya-Tsuji J.et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 398:1999;252-256.
37. Sakurai H.et al. Functional interactions of transforming growth factor beta-activated kinase 1 with IκB kinases to stimulate NF-κB activation. J. Biol. Chem. 274:1999;10641-10648.
38. Lin X.et al. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity. 10:1999;271-280.
39. Shinkura R.et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase. Nat. Genet. 22:1999;74-77.
40. Ozes O.N.et al. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85.
41. Romashkova J.A., Makarov S.S. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 401:1999;86-90.
42. Sizemore N.et al. Activation of phosphatidylinositol-3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol. Cell. Biol. 19:1999;4798-4805.
43. Harhaj E.W., Sun S.C. IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J. Biol. Chem. 274:1999;22911-22914.
44. Jin D.Y.et al. Role of adapter function in oncoprotein-mediated activation of NF-κB - human T-cell leukemia virus type I Tax interacts directly with IKKγ J. Biol. Chem. 274:1999;17402-17405.
45. Pomerantz J.L.et al. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-releated kinase. EMBO J. 18:1999;6694-6704.
46. Tojima Y.et al. NAK is an I kappa B kinase-activating kinase. Nature. 2000;. (in press).